Onconetix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1729.2%.

Top 21 shareholders own 65.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
32.5%	Altos Venture AG	2,695,931	US$2.2m	0%	no data
7.02%	Scablis Ag	581,938	US$465.6k	0%	no data
6.91%	New Horizon Health Limited	573,080	US$458.5k	0%	no data
6.78%	ZKB Asset Management	562,691	US$450.2k	7,250%	no data
5.98%	Ralph Schiess	495,903	US$396.7k	0%	no data
5.23%	Christian Bruhlmann	433,910	US$347.1k	0%	no data
0.43%	American Money Management Corporation	36,023	US$28.8k	0%	0.01%
0.24%	CincyTechUSA, Investment Arm	20,152	US$16.1k	0%	no data
0.16%	UBS Asset Management AG	12,982	US$10.4k	0%	no data
0.066%	Bank of America Corporation, Asset Management Arm	5,466	US$4.4k	74.7%	no data
0.042%	James Sapirstein	3,477	US$2.8k	0%	no data
0.042%	Simon Tarsh	3,477	US$2.8k	0%	no data
0.042%	Timothy Ramdeen	3,477	US$2.8k	0%	no data
0.041%	Ajit Singh	3,396	US$2.7k	0%	no data
0.04%	Thomas Meier	3,318	US$2.7k	0%	no data
0.03%	Jon Garfield	2,500	US$2.0k	0%	no data
0.029%	ClearArc Capital, Inc.	2,404	US$1.9k	0%	no data
0.016%	BlackRock, Inc.	1,338	US$1.1k	-0.07%	no data
0.0019%	Vuk Jemeric	159	US$127.4	0%	no data
0.00018%	Aspire Private Capital, LLC	15	US$11.9	0%	no data
0.00017%	Tower Research Capital Europe Limited	14	US$11.3	-95.6%	no data